Kolexia
Lafarie-Castet Sabine
Médecine générale
Hôpital Pellegrin
Bordeaux, France
54 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Hémorragie Hémophilie B Maladies de von Willebrand Infections dues aux prothèses Déficits en facteurs de la coagulation Hypertension artérielle Défaillance cardiaque Déficit en facteur V

Industries

Sobi
42 collaboration(s)
Dernière en 2023
Roche
19 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
9 collaboration(s)
Dernière en 2022
LFB
8 collaboration(s)
Dernière en 2023

Dernières activités

A Proof-of-concept Study to Reduce Treatment Burden in Haemophilia Participants Receiving Factor VIII and Factor IX Infusions: Ability of a Virtual-reality Based Solution Aiming to Reduce Patient Burden Related to Repetitive Intravenous Perfusions. A Proof-of-concept Study in Hemophilia Patients Receiving Prophylactic Factor VIII or Factor IX Infusions
Essai Clinique (Takeda Pharmaceutical)   10 janvier 2024
PHILEOS: Haemophilia and Bone Loss PHILEOS Study
Essai Clinique (CHU Saint-Étienne)   29 décembre 2023
Five new F10 variants in hereditary factor x deficiency detected by high-throughput sequencing.
Haemophilia : the official journal of the World Federation of Hemophilia   16 octobre 2023
Surgery in rare bleeding disorders: the prospective MARACHI study.
Research and practice in thrombosis and haemostasis   06 septembre 2023
Determinants of adherence and consequences of the transition from adolescence to adulthood among young people with severe haemophilia (TRANSHEMO): A multicentric French national observational cross-sectional study based on the FranceCoag registry.
Haemophilia : the official journal of the World Federation of Hemophilia   12 août 2023
Hémophilie
HAS Publications   20 juin 2023
TRANSHEMO: Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia - TRANSHEMO
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   13 février 2023
PO326 QUALITATIVE RESEARCH EXPLORING LIFE CHANGES IN PATIENTS LIVING WITH SEVERE HAEMOPHILIA A WITHOUT INHIBITORS TREATED WITH EMICIZUMAB
16th Annual Congress of European Association for Haemophilia and Allied Disorders 2023, 7–10 February 2023, Manchester   05 février 2023
PO068 FINAL DATA FROM B-SURE, A FRENCH MULTICENTRE STUDY IN PATIENTS WITH HAEMOPHILIA B, EVALUATING REAL-WORLD USAGE AND EFFECTIVENESS OF RECOMBINANT FACTOR IX FC (RFIXFC)
16th Annual Congress of European Association for Haemophilia and Allied Disorders 2023, 7–10 February 2023, Manchester   05 février 2023
PO080 FRENCH REAL-WORD DATA ON RIX-FP PROPHYLAXIS USE IN PATIENTS WITH HAEMOPHILIA B
16th Annual Congress of European Association for Haemophilia and Allied Disorders 2023, 7–10 February 2023, Manchester   05 février 2023